For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes ... Weekly Email Newsletter are free features that allow you to receive your ...

Potential New Drug Treatment for Multiple Sclerosis Dec. 8, 2023 — Pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis ...

Tolebrutinib did not show superiority over Aubagio (teriflunomide) in reducing relapse rates or MRI-detected inflammatory ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

More information: Repurposing Clinical MRI Archives for Multiple Sclerosis Research with a Flexible, Single-Contrast Approach: New Insights from Old Scans, Nature Communications (2025).

evaluating tolebrutinib in people with relapsing multiple sclerosis (RMS) were also published in NEJM and presented today during the Clinical Trials Plenary Session at the AAN 2025 Annual Meeting.

More data are needed on its efficacy and safety in treating relapsing multiple sclerosis ... who cared for the participants during this clinical trial; the staff members at the trial sites ...

Improving Cognitive Outcomes in Multiple Sclerosis Drs Frederick Foley and John DeLuca share clinical insights for the assessment and treatment of cognitive dysfunction in multiple sclerosis.

SAN DIEGO — Delays in visits and diagnosis for multiple sclerosis were longer in a small ... presented at the Muscular Dystrophy Association Clinical & Scientific Conference.